Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1
Clinical trial NCT07040436 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07040436
- Sponsor
- Oncodesign Precision Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-09-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.